McBride John S. 4
4 · Novus Therapeutics, Inc. · Filed Jun 14, 2018
Insider Transaction Report
Form 4
McBride John S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-13+9,100→ 9,100 totalExercise: $6.18From: 2019-06-13Exp: 2028-06-13→ Common Stock (9,100 underlying)